NIH-funded research R01 grant

SKNA as a biomarker to guide heart and brain health

Official title: SKNA as a biomarker for cardiovascular events

Funded at Indiana University Indianapolis · NIH-11350891 · Data updated 2026-11-12

A biomarker from skin nerve signals (SKNA) could help predict brain recovery after cardiac arrest and identify those at risk for atrial fibrillation recurrence after ablation.

More Cardiovascular Events research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis
NIH-funded
Lab location1 site (Indianapolis, United States)
Project startMay 1, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$488,568
NIH project number5R01HL158952-05
Project IDNIH-11350891 on NIH RePORTER

Who could benefit from this research

Could help

Patients who have experienced out-of-hospital cardiac arrest and are undergoing targeted temperature management, and patients undergoing catheter ablation for atrial fibrillation.

Less likely to help

Patients not undergoing cooling after cardiac arrest or not undergoing ablation for AF may not directly benefit from SKNA-based risk information.

What this research studies

This project tests whether skin sympathetic nerve activity (SKNA) can serve as a practical biomarker during therapeutic hypothermia after cardiac arrest to gauge neurological recovery. It also aims to use SKNA to predict which patients are more likely to have atrial fibrillation recur after catheter ablation. Researchers have developed SKNA measurement methods in canine models and have begun translating them to humans, showing correlations with heart and nervous system events. The study will apply SKNA recordings in humans undergoing targeted temperature management and post-ablation follow-up to see if it can improve risk stratification and care decisions.

Why it matters

Potential benefit: If successful, SKNA could help clinicians predict neurological outcomes after cardiac arrest and tailor AF treatment strategies to reduce recurrence.

How similar studies have gone: Prior work in canine models and early human studies suggests SKNA correlates with autonomic and cardiac events, supporting further translation.

Where this research is happening

  • Indiana University Indianapolis
    Indianapolis, United States
    Active

Researchers

  • Principal investigator: Everett, Thomas H — Indiana University Indianapolis
  • Study coordinator: Everett, Thomas H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.